$ATRA· SEC filing ·

ATRA Reports $120.8M Revenue, $32.7M Net Income, Extends Cash Runway to 2026

Atara Biotherapeutics, Inc · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) · Now $10.28

Post-detection moves

1h
1d
3d
7d
30d

Get alerts like this in real time

Push notifications the moment a signal fires. No spam, no crypto, no fluff.

Download for iOS